Kyoto, Japan

Yoshie Yoshikawa


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Otsu, JP (2000)
  • Kyoto, JP (2000 - 2003)

Company Filing History:


Years Active: 2000-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Yoshie Yoshikawa

Introduction

Yoshie Yoshikawa is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of biotechnology, particularly in cancer research and antibiotic development. With a total of 4 patents, his work has the potential to impact medical treatments and diagnostics.

Latest Patents

Yoshikawa's latest patents include a method for detecting cancer cells in resected specimens. This method involves determining changes in the expression levels of cancer-associated genes, specifically those identified in the Sequence Listing. Additionally, he has developed a kit for cancer detection based on this method. Another significant invention is the novel antibiotics TKR1912-I and TKR1912-II, which are effective against fungal infections. These antibiotics, along with their production processes, represent a breakthrough in the treatment of such infections.

Career Highlights

Yoshie Yoshikawa is associated with Takara Shuzo Co., Inc., where he continues to innovate and contribute to scientific advancements. His work has garnered attention in the medical community, particularly for its applications in cancer diagnostics and treatment.

Collaborations

Yoshikawa has collaborated with notable colleagues, including Ikunoshin Kato and Eiko Koyama, who have contributed to his research endeavors. Their combined expertise has enhanced the development of his innovative solutions.

Conclusion

Yoshie Yoshikawa's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical science and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…